US FDA’s Search For Class-Wide Vaccine Blood-Clot Effect Makes Scientific Sense, But Raises Questions
The US FDA could use data on the AstraZeneca COVID-19 vaccine to inform its review of rare blood clots seen with the Janssen vaccine. • Source: Alamy 
